Detalles de la búsqueda
1.
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.
Transfusion
; 54(2): 331-9, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23781769
2.
Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient.
Viruses
; 15(2)2023 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851504
3.
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study.
Transplant Cell Ther
; 27(3): 244.e1-244.e8, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33781522
4.
[Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide]. / La chemioterapia del microcitoma disseminato. Confronto tra carboplatino-etoposide e ciclofosfamide-epirubicina-etoposide.
Recenti Prog Med
; 96(5): 234-9, 2005 May.
Artículo
en Italiano
| MEDLINE | ID: mdl-15977652
5.
Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.
Tumori
; 88(1): 21-7, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12004845
6.
Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: definitive results of a phase II trial.
Tumori
; 90(1): 54-9, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15143973
7.
Lenalidomide in combination with dexamethasone in elderly patients with advanced, relapsed or refractory multiple myeloma and renal failure.
Mediterr J Hematol Infect Dis
; 5(1): e2013037, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23795275
Resultados
1 -
7
de 7
1
Próxima >
>>